Who is sponsoring NCT01656317?

NCT01656317 is sponsored by Oslo University Hospital.

What drugs are being tested in NCT01656317?

Interventions in NCT01656317: Early multidisciplinary rehabilitation.

Is NCT01656317 still recruiting?

NCT01656317 is currently completed. Last updated 15 March 2017.

Last reviewed 2017-03-15 · How we verify

NCT01656317: SAH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rehabilitation of Patients After Subarachnoid Hemorrhage

Completed NA Last updated 15 March 2017

What this trial tests

NA trial testing Early multidisciplinary rehabilitation in SAH in 171 participants. Completed in 20 December 2015.

Timeline

1 January 2012

Primary endpoint
27 February 2014

20 December 2015

Quick facts

Lead sponsor	Oslo University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	171
Start date	1 January 2012
Primary completion	27 February 2014
Estimated completion	20 December 2015
Sites	1 location across Norway

Drugs / interventions tested

Early multidisciplinary rehabilitation

Conditions studied

SAH — all drugs for SAH →

Sponsor

Oslo University Hospital

Who can join

18 and older, any sex, with SAH. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study's main objective will be to assess which effect early initiated rehabilitation has on the frequency of complications and the level of physical and cognitive functioning after aneurysmal subarachnoid hemorrhage (SAH). To this end the following aspects will be investigated: The frequency of complications (with special emphasis on pulmonary complications,thromboembolic events, cerebral vasospasm, unintended discontinuation of drains and lines) * Length of stay in hospitals and socio-economic impact * Physical and cognitive function in the early and chronic phase after SAH * Health-related quality of life and participation in society in the chronic phase

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Effect of early mobilization and rehabilitation on complications in aneurysmal subarachnoid hemorrhage.
Karic T, Røe C, Nordenmark TH, Becker F, et al · · 2017 · cited 54× · PMID 27058204 · DOI 10.3171/2015.12.jns151744
Effect of ICU care bundles on long-term patient-relevant outcomes: a scoping review.
Paul N, Ribet Buse E, Knauthe AC, Nothacker M, et al · · 2023 · cited 12× · PMID 36806060 · DOI 10.1136/bmjopen-2022-070962
Clinical trials in cardiac arrest and subarachnoid hemorrhage: lessons from the past and ideas for the future.
Frontera JA. · · 2013 · cited 4× · PMID 23533956 · DOI 10.1155/2013/263974

Verify or expand the search:

Other recruiting trials for SAH

Currently open trials in the same condition.

NCT03754725 — Ferritin and Iron Burden in SAH sIRB · Phase 1, PHASE2 · recruiting

Other Oslo University Hospital trials

Trials by the same sponsor.

NCT07463885 — Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure · NA · not yet recruiting
NCT07427719 — Retinopathy of Prematurity - Visual Function and Retinal Structure · not yet recruiting
NCT07403331 — Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to R · NA · recruiting
NCT07449897 — Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study · recruiting
NCT06173817 — The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients · Phase 1 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01656317 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oslo University Hospital
Last refreshed: 15 March 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01656317.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing